A. Rob P.M. Valentijn

4.2k total citations · 1 hit paper
55 papers, 3.2k citations indexed

About

A. Rob P.M. Valentijn is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, A. Rob P.M. Valentijn has authored 55 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 18 papers in Organic Chemistry and 17 papers in Immunology. Recurrent topics in A. Rob P.M. Valentijn's work include Immunotherapy and Immune Responses (17 papers), Cervical Cancer and HPV Research (11 papers) and Carbohydrate Chemistry and Synthesis (9 papers). A. Rob P.M. Valentijn is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), Cervical Cancer and HPV Research (11 papers) and Carbohydrate Chemistry and Synthesis (9 papers). A. Rob P.M. Valentijn collaborates with scholars based in Netherlands, United States and Czechia. A. Rob P.M. Valentijn's co-authors include Sjoerd H. van der Burg, Jaap Oostendorp, Marij J.P. Welters, Cornelis J.M. Melief, Jan W. Drijfhout, Gemma G. Kenter, Gert Jan Fleuren, Dorien M. A. Berends-van der Meer, Annelies P.G. Vloon and Amon R. Wafelman and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Angewandte Chemie International Edition.

In The Last Decade

A. Rob P.M. Valentijn

55 papers receiving 3.2k citations

Hit Papers

Vaccination against HPV-16 Oncoproteins for Vulvar Intrae... 2009 2026 2014 2020 2009 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
    2009 803 citations Gemma G. Kenter, Marij J.P. Welters et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Rob P.M. Valentijn Netherlands 25 1.9k 1.2k 1.2k 775 302 55 3.2k
William E. Fogler United States 38 1.4k 0.8× 1.1k 0.9× 2.0k 1.6× 208 0.3× 131 0.4× 105 3.9k
Mary Jo Turk United States 35 3.0k 1.6× 2.2k 1.8× 1.6k 1.3× 271 0.3× 144 0.5× 67 5.7k
Ian F. Hermans New Zealand 36 3.1k 1.7× 1.1k 0.9× 934 0.8× 271 0.3× 161 0.5× 107 4.2k
Guillemette Huet France 34 717 0.4× 643 0.5× 1.7k 1.4× 291 0.4× 262 0.9× 67 2.9k
Martijn H. den Brok Netherlands 26 1.3k 0.7× 799 0.7× 1.3k 1.1× 176 0.2× 258 0.9× 44 3.0k
Marianna Nuti Italy 32 1.5k 0.8× 1.6k 1.3× 1.8k 1.5× 172 0.2× 140 0.5× 132 4.1k
Liliane Goetsch France 25 965 0.5× 1.3k 1.1× 1.9k 1.6× 271 0.3× 323 1.1× 47 3.9k
Jitka Fučíková Czechia 37 3.6k 1.9× 2.8k 2.3× 1.5k 1.3× 434 0.6× 58 0.2× 70 5.6k
Vyara Matson United States 8 717 0.4× 1.6k 1.3× 1.9k 1.6× 211 0.3× 81 0.3× 8 3.4k
Herren Wu United States 40 1.3k 0.7× 1.3k 1.1× 3.0k 2.5× 567 0.7× 218 0.7× 115 5.8k

Countries citing papers authored by A. Rob P.M. Valentijn

Since Specialization
Citations

This map shows the geographic impact of A. Rob P.M. Valentijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Rob P.M. Valentijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Rob P.M. Valentijn more than expected).

Fields of papers citing papers by A. Rob P.M. Valentijn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Rob P.M. Valentijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Rob P.M. Valentijn. The network helps show where A. Rob P.M. Valentijn may publish in the future.

Co-authorship network of co-authors of A. Rob P.M. Valentijn

This figure shows the co-authorship network connecting the top 25 collaborators of A. Rob P.M. Valentijn. A scholar is included among the top collaborators of A. Rob P.M. Valentijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Rob P.M. Valentijn. A. Rob P.M. Valentijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Welters, Marij J.P., Saskia J. Santegoets, Nikki M. Loof, et al.. (2025). TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study. Nature Communications. 16(1). 4958–4958. 4 indexed citations
2.
Speetjens, Frank M., Marij J.P. Welters, Marije Slingerland, et al.. (2022). Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions. Journal for ImmunoTherapy of Cancer. 10(10). e005016–e005016. 22 indexed citations
3.
Valk, Kim S. de, Marion M. Deken, Henricus J.M. Handgraaf, et al.. (2020). First-in-Human Assessment of cRGD-ZW800-1, a Zwitterionic, Integrin-Targeted, Near-Infrared Fluorescent Peptide in Colon Carcinoma. Clinical Cancer Research. 26(15). 3990–3998. 77 indexed citations
4.
Deken, Marion M., Shadhvi S. Bhairosingh, Daniela Salvatori, et al.. (2020). Small Molecules for Multi-Wavelength Near-Infrared Fluorescent Mapping of Regional and Sentinel Lymph Nodes in Colorectal Cancer Staging. Frontiers in Oncology. 10. 586112–586112. 1 indexed citations
5.
Boogerd, Leonora S. F., Martin C. Boonstra, Hendrica A.J.M. Prevoo, et al.. (2018). Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation. Surgical Oncology. 28. 1–8. 29 indexed citations
6.
Kreer, Christoph, Suzanne van Duikeren, Willemien E. Benckhuijsen, et al.. (2014). Enhanced Cross-Presentation and Improved CD8+ T Cell Responses after Mannosylation of Synthetic Long Peptides in Mice. PLoS ONE. 9(8). e103755–e103755. 24 indexed citations
7.
Göblyös, Anikó, Kirsten J. M. Schimmel, A. Rob P.M. Valentijn, et al.. (2013). Development of a Nose Cream Containing the Synthetic Antimicrobial Peptide P60.4Ac for Eradication of Methicillin-Resistant Staphylococcus aureus Carriage. Journal of Pharmaceutical Sciences. 102(10). 3539–3544. 15 indexed citations
8.
Zeestraten, Eliane C.M., Frank M. Speetjens, Marij J.P. Welters, et al.. (2012). Addition of interferon‐α to the p53‐SLP® vaccine results in increased production of interferon‐γ in vaccinated colorectal cancer patients: A phase I/II clinical trial. International Journal of Cancer. 132(7). 1581–1591. 46 indexed citations
9.
Kenter, Gemma G., Marij J.P. Welters, A. Rob P.M. Valentijn, et al.. (2009). Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia. New England Journal of Medicine. 361(19). 1838–1847. 803 indexed citations breakdown →
10.
Leffers, Ninke, Annechien J.A. Lambeck, Marloes J.M. Gooden, et al.. (2009). Immunization with a P53 synthetic long peptide vaccine induces P53‐specific immune responses in ovarian cancer patients, a phase II trial. International Journal of Cancer. 125(9). 2104–2113. 109 indexed citations
11.
Speetjens, Frank M., Peter J.K. Kuppen, Marij J.P. Welters, et al.. (2009). Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer. Clinical Cancer Research. 15(3). 1086–1095. 143 indexed citations
12.
Melief, Cornelis J.M., Marij J.P. Welters, Margriet J. Löwik, et al.. (2008). Robust T-cell responses and clinical responses following long peptide vaccination against high risk HPV-16. 8. 2. 1 indexed citations
13.
Welters, Marij J.P., Dmitri V. Filippov, Susan J. F. van den Eeden, et al.. (2004). Chemically synthesized protein as tumour-specific vaccine: immunogenicity and efficacy of synthetic HPV16 E7 in the TC-1 mouse tumour model. Vaccine. 23(3). 305–311. 15 indexed citations
14.
Meijgaarden, Krista E. van, Annemieke Geluk, Tom H. M. Ottenhoff, et al.. (2003). Synthesis of Novel Tetrahydropyran‐Based Dipeptide Isosters by Overman Rearrangement of 2,3‐Didehydroglycosides. European Journal of Organic Chemistry. 2003(13). 2418–2427. 22 indexed citations
15.
Sliedregt, Leo A. J. M., Reshma Autar, A. Rob P.M. Valentijn, et al.. (2001). Design and synthesis of a multivalent homing device for targeting to murine CD22. Bioorganic & Medicinal Chemistry. 9(1). 85–97. 13 indexed citations
16.
Kort, Martin de, A. Rob P.M. Valentijn, Gijs A. van der Marel, et al.. (2000). Synthesis of Potent Agonists of the d-myo-Inositol 1,4,5-Trisphosphate Receptor Based on Clustered Disaccharide Polyphosphate Analogues of Adenophostin A. Journal of Medicinal Chemistry. 43(17). 3295–3303. 70 indexed citations
17.
Cohen, Louis, Elsbet Pieterman, Rick E.W. van Leeuwen, et al.. (1999). Inhibition of human smooth muscle cell proliferation in culture by farnesyl pyrophosphate analogues, inhibitors of in vitro protein:farnesyl transferase. Biochemical Pharmacology. 57(4). 365–373. 16 indexed citations
18.
Sliedregt, Leo A. J. M., Patrick C.N. Rensen, Erik T. Rump, et al.. (1999). Design and Synthesis of Novel Amphiphilic Dendritic Galactosides for Selective Targeting of Liposomes to the Hepatic Asialoglycoprotein Receptor. Journal of Medicinal Chemistry. 42(4). 609–618. 119 indexed citations
19.
Netten, P. van, et al.. (1998). The survival and growth of acid-adapted mesophilic pathogens that contaminate meat after lactic acid decontamination. Journal of Applied Microbiology. 84(4). 559–567. 19 indexed citations
20.
Kort, Martin de, A. Rob P.M. Valentijn, Gijs A. van der Marel, & Jacques H. van Boom. (1997). Synthesis of Clustered Disaccharide Polyphosphate Analogues of Adenophostin A. Tetrahedron Letters. 38(43). 7629–7632. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William E. Fogler Breakdown of academic impact, for papers by Mary Jo Turk Breakdown of academic impact, for papers by Ian F. Hermans Breakdown of academic impact, for papers by Guillemette Huet Breakdown of academic impact, for papers by Martijn H. den Brok Breakdown of academic impact, for papers by Marianna Nuti Breakdown of academic impact, for papers by Liliane Goetsch Breakdown of academic impact, for papers by Jitka Fučíková Breakdown of academic impact, for papers by Vyara Matson Breakdown of academic impact, for papers by Herren Wu
Rankless by CCL
2026